MedTrace Logo

Effective Ads for Quitting Smoking

NCT06485479 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1236

Last updated 2025-11-03

Study results available
· View outcomes & findings →

Summary

The main purpose of this trial is to identify effective quit smoking ads for people who smoke menthol cigarettes. Investigators will conduct an online randomized trial with a nationally representative sample of \~1,400 US adults (ages 21+) who smoke menthol cigarettes.

Conditions

  • Smoking Behaviors

Interventions

BEHAVIORAL

Intervention ads

The ads will be on topics to encourage quitting smoking, formatted as multi-color text with graphic elements. Trial investigators developed the ads and optimized them to be readable when delivered in an SMS text message.

BEHAVIORAL

Control ads

The ads will be on topics unrelated to quitting smoking, formatted as black text on a white field. Trial investigators developed the ads and optimized them to be readable when delivered in an SMS text message.

Sponsors & Collaborators

  • Food and Drug Administration (FDA)

    collaborator FED

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • UNC Lineberger Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Noel Brewer, PhD · University of North Carolina, Chapel Hill

  • Marissa G Hall, PhD · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-05
Primary Completion
2024-10-21
Completion
2024-10-21

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06485479 on ClinicalTrials.gov